Stay updated on Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial
Sign up to get notified when there's something new on the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page.

Latest updates to the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6, indicating a minor release. This does not modify the information presented to users.SummaryDifference0.0%

- Check22 days agoChange DetectedThe study record adds an NIH grant/contract attribution for 2015 under Other Study ID Numbers. It also introduces a Related Info section and sponsor-related entries, including Boehringer Ingelheim and a Helpful Links Provided by label.SummaryDifference0.1%

- Check36 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating a newer page build. The visible content remains unchanged.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, indicating a minor maintenance update. This does not affect the study details or how users interact with the page.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page shows Revision: v3.6.3, replacing v3.6.2. This reflects a small platform update rather than a substantive content change.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page now shows a new site revision, v3.6.2, replacing the previous v3.6.0, indicating a minor platform update. This appears in the site metadata/footer and does not modify the study information displayed.SummaryDifference0.0%

Stay in the know with updates to Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page.